HLS.TO
HLS Therapeutics Inc
Price:  
4.23 
CAD
Volume:  
1,600.00
Canada | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HLS.TO WACC - Weighted Average Cost of Capital

The WACC of HLS Therapeutics Inc (HLS.TO) is 5.6%.

The Cost of Equity of HLS Therapeutics Inc (HLS.TO) is 6.25%.
The Cost of Debt of HLS Therapeutics Inc (HLS.TO) is 5.00%.

Range Selected
Cost of equity 5.30% - 7.20% 6.25%
Tax rate 4.10% - 8.10% 6.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 6.1% 5.6%
WACC

HLS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.32 0.42
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.30% 7.20%
Tax rate 4.10% 8.10%
Debt/Equity ratio 0.68 0.68
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 6.1%
Selected WACC 5.6%